{"product_id":"orforglipron-6-mg","title":"Orforglipron – 6 mg","description":"\u003cdiv class=\"qvg-desc-rt\"\u003e\n\u003cstyle\u003e.qvg-desc-rt{font-family:'Neue Montreal',Helvetica,Arial,sans-serif;color:#6f7f84}.qvg-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:300;line-height:1.7}.qvg-desc-rt strong{color:#233137;font-weight:500}.qvg-desc-rt em{color:#8a969b}.qvg-desc-rt sup{line-height:0}.qvg-desc-rt sup a{font-size:11px;font-weight:600;color:#758084;text-decoration:none;padding:0 1px}.qvg-desc-rt sup a:hover{color:#233137}\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eOrforglipron\u003c\/strong\u003e is the first orally-bioavailable \u003cstrong\u003enon-peptide GLP-1 receptor agonist\u003c\/strong\u003e — a small molecule taken \u003cstrong\u003eonce daily by mouth\u003c\/strong\u003e, with no injection and no food or water restrictions. It targets the same GLP-1 pathway as injectable agonists through a compact synthetic structure.\u003c\/p\u003e\n\u003cp\u003eIn a 36-week \u003cstrong\u003ePhase 2\u003c\/strong\u003e obesity trial, oral orforglipron produced up to a \u003cstrong\u003e14.7% body-weight reduction\u003c\/strong\u003e, versus 2.3% on placebo — with \u003cstrong\u003e46–75%\u003c\/strong\u003e of participants losing 10% or more\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2302392\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003etype-2 diabetes\u003c\/strong\u003e, it lowered HbA1c by up to \u003cstrong\u003e2.10 points\u003c\/strong\u003e and reduced body weight by about \u003cstrong\u003e10 kg\u003c\/strong\u003e, outperforming the injectable GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01302-8\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as \u003cstrong\u003e90 oral capsules\u003c\/strong\u003e. \u003cem\u003eFigures above summarize published clinical findings on the orforglipron molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Qovigen Peptides","offers":[{"title":"Default Title","offer_id":47816106836195,"sku":"ORF(6)-90","price":290.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0777\/1029\/5267\/files\/qovigen-orforglipron-6mg-90-capsules-v3.png?v=1784489404","url":"https:\/\/qovigen.com\/products\/orforglipron-6-mg","provider":"Qovigen Peptides","version":"1.0","type":"link"}